Brief: vTv Therapeutics Says Nasdaq Indicated It Will Suspend Trading In Co’s Common Stock On June 30 Due To Failure To Satisfy Continued Listing Rule
26/06/2023 22:05
June 26 (Reuters) - vTv Therapeutics Inc VTVT.O :
* VTV THERAPEUTICS- NASDAQ INDICATED IT WILL SUSPEND TRADING
IN
CO’S COMMON STOCK ON JUNE 30 DUE TO FAILURE TO SATISFY CONTINUED
LISTING RULE
Source text for Eikon: ID:
Further company coverage: VTVT.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)